Jeanette Tetrault, MD, FACP, FASAM

Dr. Tetrault's interest involves the medical co-morbidities associated with addictive disorders. Much of her scholarly work falls into two general areas: 1) improving quality care of patients with substance use and comorbid chronic disease, and 2) addiction curriculum design and dissemination.

In the early part of her career, her work focused on understanding the prevalence of non-medical use of prescription opioids in the general population. She also developed a unique interest in the health effects of inhaled cannabis.

More recently, her work has focused on improving quality care delivery for patients with addiction and other chronic medical diseases. She has published a HRSA-funded randomized clinical trial assessing the level of counseling to accompany buprenorphine/naloxone treatment for HIV-infected opioid-dependent patients in the Journal of Substance Abuse Treatment; an NIMH-Center for Interdisciplinary Research on AIDS-funded project assessing the association between risk behaviors and antiretroviral resistance in HIV-infected patients receiving opioid agonist treatment in the Journal of Addiction Medicine; and a secondary analysis of the NIAAA-funded Veterans Aging Cohort Study (VACS) looking at the hepatic safety and antiretroviral effectiveness in HIV-infected patients receiving naltrexone in Alcoholism: Clinical and Experimental Research. The design of the VACS study led to a similar analysis looking at the hepatic safety of buprenorphine in both HIV-infected and uninfected patients which was published in The Journal of Substance Abuse Treatment. She has collaborated on numerous NIDA- and NHLBI-funded projects with colleagues at Yale.

The other main area of focus is in the dissemination of curricular innovations in the field of addiction. She published the design and implementation of a novel multi-specialty Screening, Brief Intervention, and Referral to Treatment curriculum in Substance Abuse and served as senior author on a paper describing the unique educational intervention integrated within our Addiction Recovery Clinic. She has collaborated with colleagues at Yale and other institutions on several SAMHSA and HRSA funded projects to develop curricula and workforce development strategies to address addiction. She has also focused on interprofessional education and published two scoping reviews, one focusing on undergraduate medical education and the other on interprofessional curricula in addiction medicine, both published in Academic Medicine.